SYK is activated by mutated MYD88 and drives pro-survival signaling in MYD88 driven B-cell lymphomasManit Munshi(Dana-Farber Cancer Institute), Guang Yang(Harvard University)Blood Cancer JournalJanuary 31, 202010.1038/s41408-020-0277-6Cited by 44SaveCiteExport RISWatch citationsRelated PapersThe HCK/BTK inhibitor KIN-8194 is active in MYD88-driven lymphomas and overcomes mutated BTKCys481 ibrutinib resistance|Blood|2021|28A new role for the SRC family kinase HCK as a driver of SYK activation in MYD88 mutated lymphomas|Blood Advances|2022|15